Am. J. Respir. Crit. Care Med., Volume 163, Number 4, March 2001, 918-923

Randomized, Double-blind, Placebo-controlled Crossover Trial of Modafinil in the Treatment of Residual Excessive Daytime Sleepiness in the Sleep Apnea/Hypopnea Syndrome

RUTH N. KINGSHOTT, MARJORIE VENNELLE, EMMA L. COLEMAN, HEATHER M. ENGLEMAN, THOMAS W. MACKAY, and NEIL J. DOUGLAS

Sleep Center, Respiratory Medicine Unit, The University of Edinburgh, United Kingdom

Some patients with the sleep apnea/hypopnea syndrome (SAHS) remain subjectively and objectively sleepy despite using effective continuous positive airway pressure (CPAP) therapy. The aim of this single center study was to determine the efficacy and safety of the novel wake-promoting medication modafinil in the treatment of CPAP-resistant daytime sleepiness. Thirty sleep apneics receiving effective CPAP therapy (objective use, 6.5 ± 1.1 h/night) received daily single doses of 400 mg modafinil or placebo for 2 wk in a double-blind randomized crossover design. Outcome measures were assessed at baseline and at the end of both 2-wk treatment periods. Treatment periods were separated by a 1-wk washout. Modafinil had no effect on sleepiness as measured by the Epworth Sleepiness Scale or the Multiple Sleep Latency Test (p > 0.1); however, significant improvements in alertness were found with the Maintenance of Wakefulness Test (modafinil 18.3 ± 3.9 min; placebo, 16.6 ± 5.0 min; p < 0.02). No significant treatment-related improvements in cognitive performance or quality of life were found with modafinil (all p > 0.05). There was a significant reduction in CPAP use on modafinil compared to placebo (6.3 ± 1 h/ night; 6.5 ± 1, p = 0.03). This study suggests that modafinil may improve some aspects of alertness in patients with SAHS who remain sleepy during CPAP therapy, but further studies are required to assess the significance of the reduction in CPAP use.

This article has been cited by other articles:

				B. Buyse and the participants of working group 2 Treatment effects of sleep apnoea: where are we now? Eur. Respir. Rev., December 1, 2007; 16(106): 146 - 168. [Abstract] [Full Text] [PDF]

				M. A Puhan, A. Suarez, C. Lo Cascio, A. Zahn, M. Heitz, and O. Braendli Didgeridoo playing as alternative treatment for obstructive sleep apnoea syndrome: randomised controlled trial BMJ, February 4, 2006; 332(7536): 266 - 270. [Abstract] [Full Text] [PDF]

				D. C. Randall, F. H. Cafferty, J. M. Shneerson, I. E. Smith, M. B. Llewelyn, and S. E. File Chronic treatment with modafinil may not be beneficial in patients with chronic fatigue syndrome J Psychopharmacol, November 1, 2005; 19(6): 647 - 660. [Abstract] [PDF]

				Managing excessive daytime sleepiness in adults DTB, July 1, 2004; 42(7): 52 - 56. [Abstract] [Full Text] [PDF]

				N. J. Douglas and J. Black Modafinil and Sleepiness Am. J. Respir. Crit. Care Med., December 15, 2003; 168(12): 1538 - 1539. [Full Text] [PDF]

				J. R. L. Schwartz, M. Hirshkowitz, M. K. Erman, and W. Schmidt-Nowara Modafinil as Adjunct Therapy for Daytime Sleepiness in Obstructive Sleep Apnea: A 12-Week, Open-Label Study Chest, December 1, 2003; 124(6): 2192 - 2199. [Abstract] [Full Text] [PDF]

				J. Black Pro: Modafinil Has a Role in Management of Sleep Apnea Am. J. Respir. Crit. Care Med., January 15, 2003; 167(2): 105 - 106. [Full Text] [PDF]

				C. P. Pollak Con: Modafinil Has No Role in Management of Sleep Apnea Am. J. Respir. Crit. Care Med., January 15, 2003; 167(2): 106 - 107. [Full Text] [PDF]

				A. I. Pack Should a Pharmaceutical Be Approved for the Broad Indication of Excessive Sleepiness? Am. J. Respir. Crit. Care Med., January 15, 2003; 167(2): 109 - 111. [Full Text] [PDF]

				S. Veasey, R. Rosen, B. Barzansky, I. Rosen, and J. Owens Sleep Loss and Fatigue in Residency Training: A Reappraisal JAMA, September 4, 2002; 288(9): 1116 - 1124. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Sleep-Disordered Breathing, Control of Breathing, Respiratory Muscles, and Pulmonary Function Testing in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 584 - 597. [Full Text] [PDF]

				A. I. PACK, J. E. BLACK, J. R. L. SCHWARTZ, and J. K. MATHESON Modafinil as Adjunct Therapy for Daytime Sleepiness in Obstructive Sleep Apnea Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1675 - 1681. [Abstract] [Full Text] [PDF]